Table 1. Characteristics of 119 NSCLC patients included in the study.
| Characteristics | Value | N (%) |
|---|---|---|
| Sex | Male | 91 (76.5) |
| Female | 28 (23.5) | |
| Age, yrs | Mean [range] | 67 [32–78] |
| ≤65 | 54 (45.4) | |
| >65 | 65 (54.6) | |
| ECOG PS | 0 | 35 (29.4) |
| 1 | 84 (70.6) | |
| Stage | I | 72 (60.5) |
| II | 27 (22.7) | |
| III | 20 (16.8) | |
| Histology | ADK | 64 (53.8) |
| SCC | 48 (40.3) | |
| Adenosquamous carcinoma | 1 (0.8) | |
| Large cell carcinoma | 1 (0.8) | |
| Neuroendocrine | 3 (2.5) | |
| Sarcomatoid | 2 (1.7) | |
| Smoking history | Current smoker | 47 (39.5) |
| Former smoker | 61 (51.3) | |
| Never smoker | 11 (9.2) | |
| Type of surgery | Lobectomy | 94 (79) |
| Pneumonectomy | 12 (10.1) | |
| Atypical resection | 5 (4.2) | |
| Anatomical resection | 8 (6.7) | |
| Adjuvant treatment | No | 83 (69.7) |
| Yes | 36 (30.3) | |
| Relapse | No | 69 (58.0) |
| Yes | 50 (42.0) | |
| Mutation status | TP53 mutation | 39/94 (41.5) |
| KRAS mutation | 18/105 (17.1) |
NSCLC, non-small-cell lung cancer; ECOG PS, Eastern Cooperative Oncology Group performance status; ADK, adenocarcinoma; SCC, squamous cell carcinoma.